The Hypnotic Induction Profile (HIP) in Clinical Practice and Research

Alexander, John E.; Stimpson, Katy H.; Kittle, Jessie; Spiegel, David

doi:10.1080/00207144.2021.1836646

Cited by 5 publications

(3 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A meta-analysis found that hypnotizability accounted for only 6% of the variance in response to clinical hypnosis, but found a stronger correlation between clinical effect and hypnotizability in pediatric studies (38). There are several hypnotizability assessments ranging from 10 minutes to an hour (40)(41)(42). As these can take up valuable time without clear prediction of an individual's treatment outcomes, hypnotizability assessments are not routinely used in clinical practice, but can be useful for research purposes.…”

Section: Hypnotizabilitymentioning

confidence: 99%

Clinical Hypnosis for Pediatric Gastrointestinal Disorders

Chogle

Lee

Santucci

et al. 2022

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

Functional abdominal pain disorders (FAPDs) are common in the pediatric population and are associated with a significant reduction in quality of life. Bidirectional communication of the brain-gut axis plays an important role in pain generation and perception in FAPDs. There is a paucity of data on the best approach to treat this group of disorders, with no Food and Drug Administration (FDA)-approved drugs and scarce research to substantiate the use of most medications. Use of hypnosis in pediatric FAPDs is supported by evidence and has long-term benefits of up to at least 5 years beyond completion of treatment, highlighting the importance of incorporating this therapy into the care of these patients. The mechanisms by which clinical hypnosis is beneficial in the treatment of FAPDs is not completely understood, but there is growing evidence that it impacts functioning of the brain-gut axis, potentially through influence on central pain processing, visceral sensitivity, and motility. The lack of side effects or potential for significant harm and low cost makes it an attractive option compared to pharmacologic therapies. This review addresses current barriers to clinical hypnosis including misconceptions among patients and families, lack of trained clinicians, and questions around insurance reimbursement. The recent use of telemedicine and delivery of hypnosis via audio-visual modalities allow more patients to benefit from this treatment. As the evidence base for hypnosis grows, acceptance and training will likely increase as well. Further research is needed to understand how hypnosis works and to develop tools that predict who is most likely to respond to hypnosis. Studies on cost-effectiveness in comparing hypnosis to other therapies for FAPDs will increase evidence for appropriate healthcare utilization. Because hypnosis has applications beyond pain and is child-friendly with minimal to no risk, hypnosis could be an important therapeutic tool in the wider pediatric gastrointestinal population.

show abstract

Section: Hypnotizabilitymentioning

confidence: 99%

Clinical Hypnosis for Pediatric Gastrointestinal Disorders

Chogle

Lee

Santucci

et al. 2022

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

show abstract

“…The Hypnotic Induction Profile (HIP) is a common validated measure of hypnotizability 2,47,48 . The HIP includes a standardized hypnotic induction followed by a set of specific suggestions.…”

Section: Hypnotic Induction Profilementioning

confidence: 99%

Modulation of a Stable Neurobehavioral Trait Using Repetitive Transcranial Magnetic Stimulation: A Preregistered Randomized Controlled Trial

Faerman

Stimpson

et al. 2021

Preprint

Self Cite

View full text Add to dashboard Cite

Hypnotizability, one’s ability to experience cognitive, emotional, behavioral, and physical changes in response to suggestions in the context of hypnosis, is a highly stable trait associated with increased functional connectivity between the left dorsolateral prefrontal cortex (L-DLPFC) and dorsal anterior cingulate cortex (dACC). We conducted a preregistered, triple-blinded, randomized controlled trial to test the ability of continuous theta-burst stimulation (cTBS) over a personalized neuroimaging-based L-DLPFC target to temporarily enhance hypnotizability. We tested our hypothesis in 78 patients with fibromyalgia syndrome (FMS), a functional pain disorder for which hypnosis has consistently been shown to be beneficial as a nonpharmacological treatment option. Pre-to-post cTBS change in Hypnotic Induction Profile scores (HIP; a standardized measure of hypnotizability) was significantly greater in the Active versus Sham group. Our findings suggest a causal relationship between L-DLPFC and dACC function and hypnotizability. Dose-response optimization should be further examined to formalize guidelines for future clinical utilization.Trial registrationClinicalTrials.govNCT02969707

show abstract

“…In this special issue, several articles are devoted to emerging research on the HIP. In this special issue, Alexander et al (2021) provide an overview of the HIP in clinical practice and research. The HIP was developed as a brief assessment of the trait of hypnotizability and proposes to measure both biological and sensorimotor experiences of multiple components of hypnosis.…”

mentioning

confidence: 99%

Hypnotizability: Emerging Perspectives and Research

Elkins

2021

International Journal of Clinical and Experimental Hypnosis

View full text Add to dashboard Cite

Hypnotizability refers to "An individual's ability to experience suggested alterations in physiology, sensations, emotions, thoughts, or behavior during hypnosis" (Elkins, Barabasz, Council, & Spiegel, 2015). Research has demonstrated that most people are hypnotizable and that individual differences in hypnotizability exist. In recent years, there have been important advances on perspectives and new, well-validated scales for measurement that seek to improve on older measurement instruments. Emerging research has sought to address questions such as: Is hypnotizability a natural human ability independent from formal hypnotic inductions?; Are multi-component theories most accurate to account for differences in hypnotizability?; What can we learn from a critical review of older measures of hypnotic susceptibility?; Can hypnotizability assessment be accomplished by phone?; What is being found from current study of the Hypnotic Induction Profile?; Can assessment of hypnotizability have therapeutic benefits?; Does comparison of older and newer measures of hypnotizability such as the Elkins Hypnotizability Scale point to a new "gold standard" based on contemporary research? This special issue of the IJCEH provides insights into these important questions.

show abstract

The Hypnotic Induction Profile (HIP) in Clinical Practice and Research

Cited by 5 publications

References 40 publications

Clinical Hypnosis for Pediatric Gastrointestinal Disorders

Clinical Hypnosis for Pediatric Gastrointestinal Disorders

Modulation of a Stable Neurobehavioral Trait Using Repetitive Transcranial Magnetic Stimulation: A Preregistered Randomized Controlled Trial

Hypnotizability: Emerging Perspectives and Research

Contact Info

Product

Resources

About